Managing the AI Software Development Life Cycle

We know how to manage conventional Software Development Life Cycles (SDLCs). How does introducing AI/ML into the SDLC change things? How much of what you do already can be leveraged with this new technology? Will AI/ML drive significant changes to your QMS in design controls and risk management? These and other questions will be addressed in an open panel and participant discussion that cuts through the “AI/ML is different” hype.

View PDF Presentation

Moderator

• Eric Henry, Senior Quality & Regulatory Compliance Advisor, FDA & Life Sciences Practice, King & Spalding
• Kip Wolf, President & Principal Consultant, Thaumazo Bioscience Management, Inc.